Arthrex Plates, Screws and Pins, and Washers
ARTHREX, INC. · Decision date Oct 29, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision on October 29, 2026, for K263602, submitted by Arthrex, Inc. of Naples, Florida, covering Arthrex Plates, Screws and Pins, and Washers. The submission was received September 30, 2026, and falls under 21 CFR 888.3030, Single/Multiple Component Metallic Bone Fixation Appliances And Accessories, Class II, with primary product code HRS and subsequent codes HWC, HTN, MBI and JDR. The review panel and regulation medical specialty are both orthopedic.
SESE in a 510(k) pathway means the device was cleared as substantially equivalent to a predicate; it is not a PMA approval. The record shows a special summary and states the submission was not reviewed by a third party, was not a combination product, and had no authorized predetermined change control plan. The specific components, materials, indications and any comparison to the predicate are not given in the available excerpts and would require the full FDA decision documents.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Orthopedic
- Decision date
- Oct 29, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K263602
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- ARTHREX, INC.
- Product code
- HRS
- Decision code
- SESE
- Decision date
- Oct 29, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Plate, Fixation, Bone.
- Applicant
- Arthrex, Inc.
- Product code
- HRS
- FDA device class
- 2
FDA decision timeline
K263602 received
Application receipt date recorded by FDA.
K263602 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code HRS
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
HERO Sternal Closure SystemK262939 | Hero Orthopedics, LLC | 510(k) clearance | Nov 2, 2026 | FDA |
| Skeletal Dynamics, Inc. | 510(k) clearance | Oct 26, 2026 | FDA | |
ANTHEM Fracture SystemK262779 | GLOBUS MEDICAL, INC. | 510(k) clearance | Oct 23, 2026 | FDA |
Tempo Plating SystemK263407 | Pace Surgical | 510(k) clearance | Oct 23, 2026 | FDA |
Park's Pectus SystemK263269 | Tdm Co., Ltd. | 510(k) clearance | Oct 15, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Arthrex, Inc.
- Headquarters
- Not reported
- Brand website
- arthrex.com
- FDA applicant address
- Naples, FL
Sources and methodology
- Original FDA record: K263602
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records


